| Literature DB >> 19470510 |
Stathis D Kotsakis1, Costas C Papagiannitsis, Eva Tzelepi, Leonidas S Tzouvelekis, Vivi Miriagou.
Abstract
CMY-30, a Val211Gly mutant of CMY-2 cephalosporinase, was derived by mutagenesis. The hydrolytic efficiency of CMY-30 against expanded-spectrum cephalosporins was higher than that of CMY-2 due to increased k(cat) values. Findings indicate a role of the Omega loop residue 211 in determining the substrate specificities of CMYs also corroborated by modeling studies.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19470510 PMCID: PMC2715598 DOI: 10.1128/AAC.00219-09
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191